Official Title
Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection
Brief Summary

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infects host-cells via ACE2-receptors, which leads to pneumonia (COVID-19) but also can lead to myocarditis (acute myocardial injury) and chronic damage to the cardiovascular system. Therefore, cardiovascular protection may be necessary when treating patients with COVID-19 infection. This may especially be necessary in patients with cardiovascular diseases, risk factors, and co-medication.

Completed
Cardiovascular Diseases
Cardiovascular Risk Factor
SARS

Diagnostic Test: Assessment of cardiovascular diseases and cardiovascular risk factors

At inclusion, patients will be screened for pre-existing cardiovascular diseases and cardiovascular risk factors, as well as medication.

Eligibility Criteria

Inclusion Criteria:

- Patients with suspected SARS-CoV2/Covid-19 infection

Exclusion Criteria:

- Unwillingness to participate

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
Germany
Locations

University Hospital Essen
Essen, NRW, Germany

Tienush Rassaf, MD, Principal Investigator
University Hospital Essen, Deparment of Cardiology and Vascular Medicine

University Hospital, Essen
NCT Number
MeSH Terms
Cardiovascular Diseases